Piramal Life Sciences
BSE: 532979 | NSE: PIRLIFE | ISIN: INE122J01015 | Pharmaceuticals
 |
Half Yearly Results of Piramal Life Sciences |
------------------- in Rs. Cr. ------------------- |
| Sep '08 | Mar '09 | Sep '09 | ||||||
| ||||||||
|
||||||||
| 6 mths | 6 mths | 6 mths | ||||||
|
||||||||
| Sales Turnover | -- | 2.28 | 4.28 | |||||
| Other Income | 0.01 | -- | -- | |||||
| Total Income | 0.01 | 2.28 | 4.28 | |||||
| Total Expenses | 40.88 | 52.13 | 47.72 | |||||
| Operating Profit | -40.88 | -49.85 | -43.44 | |||||
| Profit On Sale Of Assets | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | |||||
| Gross Profit | -40.87 | -49.85 | -43.44 | |||||
| Interest | 1.85 | 7.67 | 10.96 | |||||
| PBDT | -42.72 | -57.52 | -54.40 | |||||
| Depreciation | 4.78 | 5.02 | 5.20 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | |||||
| PBT | -47.50 | -62.54 | -59.60 | |||||
| Tax | 0.08 | 0.73 | -- | |||||
| Net Profit | -47.58 | -63.27 | -59.60 | |||||
| Prior Year Income/Expenses | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | |||||
| Dividend | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | |||||
| Earnings Per Share(Rs) | -- | -- | -- | |||||
| Book Value(Rs) | -- | -- | -- | |||||
| Equity | 25.45 | 25.45 | 25.45 | |||||
| Reserves | -- | 158.21 | -- | |||||
| Face Value(Rs) | 10.00 | 10.00 | 10.00 | |||||
| ||||||||
| Source : Religare Technova | ||||||||
| Explore Piramal Life connections | ||||||||
| ||||||||
